詳細検索

詳細検索

お問い合わせ お問い合わせ

Peripheral Stent Implants Market Insights, Competitive Landscape, and Market Forecast - 2033

Peripheral Stent Implants Market Insights, Competitive Landscape, and Market Forecast - 2033


The global peripheral stent implants market is experiencing notable expansion as the burden of peripheral artery diseases continues to rise worldwide. Peripheral stents are essential medical device... もっと見る

 

 

出版社
Fairfield Market Research
フェアフィールドマーケットリサーチ
出版年月
2026年4月10日
電子版価格
US$4,995
シングルユーザライセンス
ライセンス・価格情報/注文方法はこちら
納期
通常5営業日以内
ページ数
192
言語
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

The global peripheral stent implants market is experiencing notable expansion as the burden of peripheral artery diseases continues to rise worldwide. Peripheral stents are essential medical devices used to treat narrowed or blocked arteries outside the coronary region, particularly in the lower limbs and carotid arteries. With the growing adoption of minimally invasive procedures and increasing awareness of vascular health, the demand for peripheral stent implants is gaining strong momentum. Advancements in interventional techniques and device design are further contributing to improved patient outcomes, positioning the market for sustained growth.

Market Insights

The peripheral stent implants market is projected to reach USD 4.2 billion in 2026 and is expected to grow to USD 6.4 billion by 2033, registering a compound annual growth rate (CAGR) of 6.20% during the forecast period. This steady growth reflects the increasing incidence of peripheral artery disease (PAD), particularly among aging populations and individuals with chronic health conditions such as diabetes and hypertension. Continuous innovation in stent technologies, including drug-eluting and covered stents, is also supporting market expansion by enhancing procedural success rates and reducing complications.

Market Drivers

A major factor driving the market is the rising prevalence of lifestyle-related diseases that contribute to vascular complications. Sedentary lifestyles, poor dietary habits, and increasing tobacco use are significantly elevating the risk of arterial blockages, thereby increasing the need for effective treatment solutions such as stent implantation.

Technological advancements in stent design and materials are also playing a crucial role in market growth. Drug-eluting stents, which release therapeutic agents to prevent restenosis, are gaining widespread acceptance due to their improved clinical outcomes. Additionally, the development of flexible and durable stents allows physicians to treat complex lesions more effectively.

The growing preference for minimally invasive procedures is another key driver. Compared to traditional surgical methods, stent-based interventions offer reduced recovery times, lower risk of complications, and shorter hospital stays. This shift in treatment preference is encouraging healthcare providers to adopt advanced stenting solutions.

Business Opportunities

The peripheral stent implants market presents significant opportunities for industry participants. Emerging economies are becoming key growth hubs due to increasing healthcare investments, improving infrastructure, and rising patient awareness. Countries across Asia Pacific and Latin America are witnessing higher adoption rates of advanced medical technologies, creating new avenues for market expansion.

Innovation remains a critical area of opportunity. Companies investing in next-generation stents with enhanced biocompatibility, better drug delivery systems, and improved structural integrity are likely to gain a competitive advantage. Furthermore, the integration of imaging technologies with stenting procedures is expected to enhance precision and treatment outcomes.

Strategic initiatives such as partnerships, mergers, and acquisitions are also shaping the competitive landscape. Leading players are focusing on expanding their global footprint and strengthening their product portfolios to address diverse clinical needs.

Regional Analysis

North America continues to dominate the peripheral stent implants market, supported by a high prevalence of vascular diseases, well-established healthcare systems, and rapid adoption of advanced technologies. The presence of major market players and favorable reimbursement frameworks further strengthens the region’s position.

Europe holds a substantial share of the market, driven by increasing healthcare awareness and a growing elderly population. The region is characterized by steady adoption of innovative medical devices and supportive healthcare policies.

Asia Pacific is anticipated to register the fastest growth over the forecast period. Factors such as rising healthcare expenditure, large patient populations, and improving access to medical services are fueling demand in countries like India and China. Government initiatives aimed at enhancing healthcare infrastructure are also contributing to regional growth.

Latin America and the Middle East and Africa are gradually emerging as potential markets. Improvements in healthcare delivery systems and increasing focus on early diagnosis and treatment are expected to support market development in these regions.

Key Players

• Abbott Laboratories

• Braun Melsungen AG

• Biotronik SE & Co. KG

• Cook Medical, Inc.

• Boston Scientific Corporation

• iVascular SLU

• Cardinal Health, Inc.

• Terumo Corporation

• Medtronic Plc.

• L. Gore & Associates, Inc.

• R. Bard, Inc.

• MicroPort Scientific Corporation

The peripheral stent implants market is set to witness consistent growth, driven by the increasing prevalence of vascular disorders and continuous advancements in medical technology. As healthcare providers increasingly adopt minimally invasive approaches, the demand for efficient and reliable stent solutions is expected to rise. Companies that prioritize innovation, strategic expansion, and quality enhancement will be well-positioned to capitalize on the evolving market landscape.

Market Segmentation

By Product

• Bare Metal Stents (BMS)

• Covered Stents

• Drug Eluting Stents (DES)

By Artery

• Carotid Artery Stents

• Fem-Pop Artery Stents

• Iliac Artery Stents

• Infrapop Artery Stents

By End User

• Hospitals

• Ambulatory Surgical Centers/Outpatient

By Region

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East and Africa

ページTOPに戻る


Table of Contents

1. Executive Summary
1.1. Global Peripheral Stent Implants Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Peripheral Stent Implants Market Outlook, 2020-2033
3.1. Global Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn), 2020-2033
3.1.1. Bare Metal Stents (BMS)
3.1.2. Covered Stents
3.1.3. Drug Eluting Stents (DES)
3.2. Global Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn), 2020-2033
3.2.1. Carotid Artery Stents
3.2.2. Fem-Pop Artery Stents
3.2.3. Iliac Artery Stents
3.2.4. Infrapop Artery Stents
3.3. Global Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn), 2020-2033
3.3.1. Hospitals
3.3.2. Ambulatory Surgical Centers/Outpatient
3.4. Global Peripheral Stent Implants Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
4. North America Peripheral Stent Implants Market Outlook, 2020-2033
4.1. North America Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn), 2020-2033
4.1.1. Bare Metal Stents (BMS)
4.1.2. Covered Stents
4.1.3. Drug Eluting Stents (DES)
4.2. North America Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn), 2020-2033
4.2.1. Carotid Artery Stents
4.2.2. Fem-Pop Artery Stents
4.2.3. Iliac Artery Stents
4.2.4. Infrapop Artery Stents
4.3. North America Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn), 2020-2033
4.3.1. Hospitals
4.3.2. Ambulatory Surgical Centers/Outpatient
4.4. North America Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.4.1. U.S. Peripheral Stent Implants Market Outlook, by Product, 2020-2033
4.4.2. U.S. Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
4.4.3. U.S. Peripheral Stent Implants Market Outlook, by End User, 2020-2033
4.4.4. Canada Peripheral Stent Implants Market Outlook, by Product, 2020-2033
4.4.5. Canada Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
4.4.6. Canada Peripheral Stent Implants Market Outlook, by End User, 2020-2033
4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Peripheral Stent Implants Market Outlook, 2020-2033
5.1. Europe Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn), 2020-2033
5.1.1. Bare Metal Stents (BMS)
5.1.2. Covered Stents
5.1.3. Drug Eluting Stents (DES)
5.2. Europe Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn), 2020-2033
5.2.1. Carotid Artery Stents
5.2.2. Fem-Pop Artery Stents
5.2.3. Iliac Artery Stents
5.2.4. Infrapop Artery Stents
5.3. Europe Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn), 2020-2033
5.3.1. Hospitals
5.3.2. Ambulatory Surgical Centers/Outpatient
5.4. Europe Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.4.1. Germany Peripheral Stent Implants Market Outlook, by Product, 2020-2033
5.4.2. Germany Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
5.4.3. Germany Peripheral Stent Implants Market Outlook, by End User, 2020-2033
5.4.4. Italy Peripheral Stent Implants Market Outlook, by Product, 2020-2033
5.4.5. Italy Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
5.4.6. Italy Peripheral Stent Implants Market Outlook, by End User, 2020-2033
5.4.7. France Peripheral Stent Implants Market Outlook, by Product, 2020-2033
5.4.8. France Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
5.4.9. France Peripheral Stent Implants Market Outlook, by End User, 2020-2033
5.4.10. U.K. Peripheral Stent Implants Market Outlook, by Product, 2020-2033
5.4.11. U.K. Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
5.4.12. U.K. Peripheral Stent Implants Market Outlook, by End User, 2020-2033
5.4.13. Spain Peripheral Stent Implants Market Outlook, by Product, 2020-2033
5.4.14. Spain Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
5.4.15. Spain Peripheral Stent Implants Market Outlook, by End User, 2020-2033
5.4.16. Russia Peripheral Stent Implants Market Outlook, by Product, 2020-2033
5.4.17. Russia Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
5.4.18. Russia Peripheral Stent Implants Market Outlook, by End User, 2020-2033
5.4.19. Rest of Europe Peripheral Stent Implants Market Outlook, by Product, 2020-2033
5.4.20. Rest of Europe Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
5.4.21. Rest of Europe Peripheral Stent Implants Market Outlook, by End User, 2020-2033
5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Peripheral Stent Implants Market Outlook, 2020-2033
6.1. Asia Pacific Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn), 2020-2033
6.1.1. Bare Metal Stents (BMS)
6.1.2. Covered Stents
6.1.3. Drug Eluting Stents (DES)
6.2. Asia Pacific Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn), 2020-2033
6.2.1. Carotid Artery Stents
6.2.2. Fem-Pop Artery Stents
6.2.3. Iliac Artery Stents
6.2.4. Infrapop Artery Stents
6.3. Asia Pacific Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn), 2020-2033
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers/Outpatient
6.4. Asia Pacific Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.4.1. China Peripheral Stent Implants Market Outlook, by Product, 2020-2033
6.4.2. China Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
6.4.3. China Peripheral Stent Implants Market Outlook, by End User, 2020-2033
6.4.4. Japan Peripheral Stent Implants Market Outlook, by Product, 2020-2033
6.4.5. Japan Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
6.4.6. Japan Peripheral Stent Implants Market Outlook, by End User, 2020-2033
6.4.7. South Korea Peripheral Stent Implants Market Outlook, by Product, 2020-2033
6.4.8. South Korea Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
6.4.9. South Korea Peripheral Stent Implants Market Outlook, by End User, 2020-2033
6.4.10. India Peripheral Stent Implants Market Outlook, by Product, 2020-2033
6.4.11. India Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
6.4.12. India Peripheral Stent Implants Market Outlook, by End User, 2020-2033
6.4.13. Southeast Asia Peripheral Stent Implants Market Outlook, by Product, 2020-2033
6.4.14. Southeast Asia Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
6.4.15. Southeast Asia Peripheral Stent Implants Market Outlook, by End User, 2020-2033
6.4.16. Rest of SAO Peripheral Stent Implants Market Outlook, by Product, 2020-2033
6.4.17. Rest of SAO Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
6.4.18. Rest of SAO Peripheral Stent Implants Market Outlook, by End User, 2020-2033
6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Peripheral Stent Implants Market Outlook, 2020-2033
7.1. Latin America Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn), 2020-2033
7.1.1. Bare Metal Stents (BMS)
7.1.2. Covered Stents
7.1.3. Drug Eluting Stents (DES)
7.2. Latin America Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn), 2020-2033
7.2.1. Carotid Artery Stents
7.2.2. Fem-Pop Artery Stents
7.2.3. Iliac Artery Stents
7.2.4. Infrapop Artery Stents
7.3. Latin America Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn), 2020-2033
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers/Outpatient
7.4. Latin America Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.4.1. Brazil Peripheral Stent Implants Market Outlook, by Product, 2020-2033
7.4.2. Brazil Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
7.4.3. Brazil Peripheral Stent Implants Market Outlook, by End User, 2020-2033
7.4.4. Mexico Peripheral Stent Implants Market Outlook, by Product, 2020-2033
7.4.5. Mexico Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
7.4.6. Mexico Peripheral Stent Implants Market Outlook, by End User, 2020-2033
7.4.7. Argentina Peripheral Stent Implants Market Outlook, by Product, 2020-2033
7.4.8. Argentina Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
7.4.9. Argentina Peripheral Stent Implants Market Outlook, by End User, 2020-2033
7.4.10. Rest of LATAM Peripheral Stent Implants Market Outlook, by Product, 2020-2033
7.4.11. Rest of LATAM Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
7.4.12. Rest of LATAM Peripheral Stent Implants Market Outlook, by End User, 2020-2033
7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Peripheral Stent Implants Market Outlook, 2020-2033
8.1. Middle East & Africa Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn), 2020-2033
8.1.1. Bare Metal Stents (BMS)
8.1.2. Covered Stents
8.1.3. Drug Eluting Stents (DES)
8.2. Middle East & Africa Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn), 2020-2033
8.2.1. Carotid Artery Stents
8.2.2. Fem-Pop Artery Stents
8.2.3. Iliac Artery Stents
8.2.4. Infrapop Artery Stents
8.3. Middle East & Africa Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn), 2020-2033
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers/Outpatient
8.4. Middle East & Africa Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.4.1. GCC Peripheral Stent Implants Market Outlook, by Product, 2020-2033
8.4.2. GCC Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
8.4.3. GCC Peripheral Stent Implants Market Outlook, by End User, 2020-2033
8.4.4. South Africa Peripheral Stent Implants Market Outlook, by Product, 2020-2033
8.4.5. South Africa Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
8.4.6. South Africa Peripheral Stent Implants Market Outlook, by End User, 2020-2033
8.4.7. Egypt Peripheral Stent Implants Market Outlook, by Product, 2020-2033
8.4.8. Egypt Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
8.4.9. Egypt Peripheral Stent Implants Market Outlook, by End User, 2020-2033
8.4.10. Nigeria Peripheral Stent Implants Market Outlook, by Product, 2020-2033
8.4.11. Nigeria Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
8.4.12. Nigeria Peripheral Stent Implants Market Outlook, by End User, 2020-2033
8.4.13. Rest of Middle East Peripheral Stent Implants Market Outlook, by Product, 2020-2033
8.4.14. Rest of Middle East Peripheral Stent Implants Market Outlook, by Artery, 2020-2033
8.4.15. Rest of Middle East Peripheral Stent Implants Market Outlook, by End User, 2020-2033
8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Abbott Laboratories
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Braun Melsungen AG
9.4.3. Biotronik SE & Co. KG
9.4.4. Cook Medical, Inc.
9.4.5. Boston Scientific Corporation
9.4.6. iVascular SLU
9.4.7. Cardinal Health, Inc.
9.4.8. Terumo Corporation
9.4.9. Medtronic Plc.
9.4.10. L. Gore & Associates, Inc.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(stent)の最新刊レポート


よくあるご質問


Fairfield Market Research社はどのような調査会社ですか?


Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/05/18 10:29

159.99 円

186.04 円

215.58 円

ページTOPに戻る